Arvinas, Inc.
Pharmaceutical Preparations · New Haven, CT, United States
- PrincipalsAndrew SaikChief Financial OfficerAngela M CacaceChief Scientific OfficerDavid K LoomisVP, Chief Accounting Officerand 4 more
- CompanyArvinas, Inc.New Haven, CT, United States
- Phone line+1 (203) 535-1456General business
Arvinas, Inc. is an SEC-registered Nasdaq-listed company (ticker ARVN) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 7
Chief executive
Randy TeelPresident and CEO
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Andrew Saik — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Angela M Cacace — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David K Loomis — VP, Chief Accounting Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Noah Berkowitz — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Amarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capability